These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2966029)

  • 1. Atrial natriuretic peptide during acute treatment of congestive heart failure.
    Berglund H; Bevegård S; Carlens P; Hedner J; Hedner T
    Clin Physiol; 1988 Apr; 8(2):155-62. PubMed ID: 2966029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased plasma levels of atrial natriuretic peptide in patients with congestive heart failure.
    Pettersson A; Hedner J; Hedner T; Held P; Swedberg K; Towle AC
    Eur Heart J; 1986 Aug; 7(8):693-6. PubMed ID: 2945719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma levels of atrial natriuretic peptide at rest and during exercise in heart failure--influence of cardiac rhythm and haemodynamics.
    Berglund H; Jensen-Urstad M; Theodorsson E; Bevegård S
    Clin Physiol; 1991 Mar; 11(2):183-96. PubMed ID: 1828196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial natriuretic peptide release is more dependent on atrial filling volume than on filling pressure in chronic congestive heart failure.
    Globits S; Frank H; Pacher B; Huelsmann M; Ogris E; Pacher R
    Am Heart J; 1998 Apr; 135(4):592-7. PubMed ID: 9539472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial natriuretic peptide in severe heart failure: response to controlled changes in atrial pressures during intravenous nitroglycerin therapy.
    Lewis BS; Makhoul N; Dakak N; Flugelman MY; Yechiely H; Halon DA; Kahana L
    Am Heart J; 1992 Oct; 124(4):1009-16. PubMed ID: 1388322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Responses of plasma concentrations of A type natriuretic peptide and B type natriuretic peptide to alacepril, an angiotensin-converting enzyme inhibitor, in patients with congestive heart failure.
    Yoshimura M; Yasue H; Tanaka H; Kikuta K; Sumida H; Kato H; Jougasaki M; Nakao K
    Br Heart J; 1994 Dec; 72(6):528-33. PubMed ID: 7857734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrial natriuretic peptide in congestive heart failure: postural changes and reset with chronic captopril therapy.
    Rouleau JL; Bichet D; Kortas C
    Am Heart J; 1988 May; 115(5):1060-7. PubMed ID: 2966547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiorenal and neurohumoral effects of endogenous atrial natriuretic peptide in dogs with severe congestive heart failure using a specific antagonist for guanylate cyclase-coupled receptors.
    Wada A; Tsutamoto T; Matsuda Y; Kinoshita M
    Circulation; 1994 May; 89(5):2232-40. PubMed ID: 7910118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of continuous positive airway pressure on mitral regurgitant fraction and atrial natriuretic peptide in patients with heart failure.
    Tkacova R; Liu PP; Naughton MT; Bradley TD
    J Am Coll Cardiol; 1997 Sep; 30(3):739-45. PubMed ID: 9283534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Digitalis increases brain natriuretic peptide in patients with severe congestive heart failure.
    Tsutamoto T; Wada A; Maeda K; Hisanaga T; Fukai D; Maeda Y; Ohnishi M; Mabuchi N; Kinoshita M
    Am Heart J; 1997 Nov; 134(5 Pt 1):910-6. PubMed ID: 9398103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical application of atrial natriuretic polypeptide in patients with congestive heart failure: beneficial effects on left ventricular function.
    Saito Y; Nakao K; Nishimura K; Sugawara A; Okumura K; Obata K; Sonoda R; Ban T; Yasue H; Imura H
    Circulation; 1987 Jul; 76(1):115-24. PubMed ID: 2954723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of atrial natriuretic peptide secretion in patients with severe congestive heart failure.
    Uretsky BF; Verbalis JG; Murali S; Betschart AR; Kolesar JA; Reddy PS
    J Clin Endocrinol Metab; 1990 Jul; 71(1):146-51. PubMed ID: 2142492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High plasma levels of N-terminal pro-atrial natriuretic peptide associated with low anxiety in severe heart failure.
    Herrmann-Lingen C; Binder L; Klinge M; Sander J; Schenker W; Beyermann B; von Lewinski D; Pieske B
    Psychosom Med; 2003; 65(4):517-22. PubMed ID: 12883099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catecholamines, renin-angiotensin-aldosterone system, and atrial natriuretic peptide at rest and during submaximal exercise in patients with congestive heart failure.
    Kinugawa T; Ogino K; Kitamura H; Saitoh M; Omodani H; Osaki S; Hisatome I; Miyakoda H
    Am J Med Sci; 1996 Sep; 312(3):110-7. PubMed ID: 8783676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acute changes in the hemodynamic profile and circulating levels of atrial natriuretic peptide induced by dobutamine in severe heart failure].
    La Vecchia L; Bottero M; Centofante P; Bedogni F; Ometto R; Cera A; Fortunato A
    G Ital Cardiol; 1996 Aug; 26(8):863-74. PubMed ID: 9005168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of atrial natriuretic peptide on left ventricular performance in conscious dogs before and after pacing-induced heart failure.
    Ohte N; Cheng CP; Suzuki M; Little WC
    J Pharmacol Exp Ther; 1999 Nov; 291(2):589-95. PubMed ID: 10525076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possibility of downregulation of atrial natriuretic peptide receptor coupled to guanylate cyclase in peripheral vascular beds of patients with chronic severe heart failure.
    Tsutamoto T; Kanamori T; Morigami N; Sugimoto Y; Yamaoka O; Kinoshita M
    Circulation; 1993 Jan; 87(1):70-5. PubMed ID: 8093432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infusion of atrial natriuretic peptide to patients with congestive heart failure.
    Goy JJ; Waeber B; Nussberger J; Bidiville J; Biollaz J; Nicod P; Mooser V; Kappenberger L; Brunner HR
    J Cardiovasc Pharmacol; 1988; 12(5):562-70. PubMed ID: 2468056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diurnal change of plasma atrial natriuretic peptide concentrations in patients with congestive heart failure.
    Yoshino F; Sakuma N; Date T; Unoki T; Fukagawa K; Miyamoto T; Matsuda Y
    Am Heart J; 1989 Jun; 117(6):1316-9. PubMed ID: 2524954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance.
    Abassi Z; Karram T; Ellaham S; Winaver J; Hoffman A
    Pharmacol Ther; 2004 Jun; 102(3):223-41. PubMed ID: 15246247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.